» Articles » PMID: 34524722

Patients with Ehlers-Danlos Syndrome on the Diagnostic Odyssey: Rethinking Complexity and Difficulty As a Hero's Journey

Overview
Specialty Genetics
Date 2021 Sep 15
PMID 34524722
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Patients with hypermobile Ehlers-Danlos syndrome, an hereditary disorder of the connective tissue, often face a long and difficult diagnostic odyssey in pursuit of a name for their condition. Clinicians may dismiss subjective symptoms of chronic pain, thus prolonging patients' odysseys and worsening their care and satisfaction and creating antagonisms in the patient-provider relationship. A greater understanding of patient experiences is necessary in order to decrease burdens of this relationship and to improve care. To that end, we conducted 22 in-depth, semistructured interviews with individuals who had undergone this diagnostic odyssey. We focused on the impact that the odyssey had on their lives, both inside and outside the clinic. Through narrative analysis, we found a sort of "hero's journey" in the description of their cases, highlighting issues of uncertainty and integration as well as honoring their struggles. Interviewees had encountered difficulties in working with clinicians, in multiplying symptoms, and in negative psychosocial consequences. Attention to patients' lived experience may help to build empathy and understanding for the difficult and complex clinical situation presented by Ehlers-Danlos syndrome. Using the hero's journey as a lens onto this experience allows for a more patient-centered approach to this understanding and has potential value for comprehension of other complex diseases and invisible illnesses.

Citing Articles

An evaluation of practices and policies used in genetics clinics across the United States to manage referrals for Ehlers-Danlos and hypermobility syndromes.

Boucher L, Nestler B, Groepper D, Quillin J, Deyle D, Halverson C Genet Med Open. 2025; 3:101960.

PMID: 39996015 PMC: 11849115. DOI: 10.1016/j.gimo.2024.101960.


Navigating HOPE (Hypermobile Online Pain managemEnt): Perspectives and Experiences From People With Hypermobile Ehlers-Danlos Syndrome or Hypermobility Spectrum Disorder on a Condition-Specific Online Pain Management Programme.

Chew M, Ilhan E, Dennis S, Nicholson L, Kobayashi S, Chan C Health Expect. 2025; 28(1):e70186.

PMID: 39962637 PMC: 11832430. DOI: 10.1111/hex.70186.


The Financial Impact of Ehlers-Danlos Syndromes on Patients in the United States in 2022.

Schubart J, Schaefer E, Mills S, Knight D, Shen C, Francomano C Mayo Clin Proc Innov Qual Outcomes. 2025; 9(1):100586.

PMID: 39790860 PMC: 11713486. DOI: 10.1016/j.mayocpiqo.2024.11.003.


Patient and parent knowledge, understanding, and concerns after a new diagnosis of Ehlers Danlos syndrome.

Jones J, Black L, Black W Orphanet J Rare Dis. 2024; 19(1):493.

PMID: 39736684 PMC: 11684232. DOI: 10.1186/s13023-024-03517-y.


Comorbidity, misdiagnoses, and the diagnostic odyssey in patients with hypermobile Ehlers-Danlos syndrome.

Halverson C, Cao S, Perkins S, Francomano C Genet Med Open. 2024; 1(1):100812.

PMID: 39669244 PMC: 11613559. DOI: 10.1016/j.gimo.2023.100812.